Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 98

Consumption Research and Development Treatment Programs 98

Cannabis Law Report

MAY 28, 2021

(CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip “), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). About Field Trip Health Ltd. KCSA Strategic Communications.

Conditions 98

Conditions Research and Development Therapy Events 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Veriheal

MARCH 17, 2022

However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” Although it is true that psychedelic consumers do report many psychosis-like symptoms, this can be attributed to the use of other psychoactive drugs and pre-existing or underlying mental health conditions. .

Research and Development 98

Research and Development Therapy Conditions History 98

Cannabis Law Report

AUGUST 17, 2022

Ohio State Legal Studies Research Paper No. According to its sponsors and supporters, the Safe and Fair Enforcement (‘SAFE’) Banking Act would help address the challenges faced by small cannabis businesses that cannot currently access banking services or loans. Ohio State Legal Studies Research Paper No. Cat Packer.

Banking 98

Banking Access Research and Development Compliance 98

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JUNE 28, 2021

Our expertise in neurology and Curaleaf International’s knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,” says Marco Castino, Head of Region Europe in Zambon. The market for medical cannabis in Germany. About Curaleaf International. About Zambon Spa.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Veriheal

AUGUST 21, 2023

million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.

Therapy 95

Therapy Research and Development Treatment Environment 95

Leafwell

JANUARY 2, 2021

Not only in the acceptance of the plant as a medicine, but the number of people who have access to this alternative and our understanding of how it works with our bodies. As research has developed, the list of qualifying conditions for getting a medical marijuana card has expanded within medical programs because.

Conditions 59

Conditions Research and Development Programs Access 59

NORML

APRIL 5, 2019

She also signed bills to allow medical cannabis to be administered to patients while at school, and a broader medical expansion bill that adds several new qualifying conditions and patient protections. Governor Jared Polis (D) of Colorado signed legislation into law to add autism as a medical cannabis qualifying condition. CA resident?

Legislation 207

Legislation Banking Hemp Compliance 207

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 81

Research and Development Conditions Data Patients 81

CannaMD

OCTOBER 6, 2020

As legalization opens new pathways for cannabis research, studies continue to expand the growing list of marijuana’s medical benefits. According to Eric Brown , lead researcher in the study at McMaster University: These findings suggest real therapeutic potential for cannabinoids as antibiotics. Medical Marijuana & MRSA.

Research and Development 116

Research and Development Marijuana Cannabinoids Conditions 116

Medicinal Marijuana Association

AUGUST 27, 2019

Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion 124

Digestion Treatment Conditions Research and Development 124

Cannabis Law Report

JUNE 5, 2021

On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Supplier development: Genetics, agro 4.0, Yahoo Finance reports.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

LifeCannMD

JANUARY 31, 2025

#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. But what truly matters is how these improvements translate into real life.

Conditions 52

Conditions Research and Development Cannabinoids Sleep 52

MGC Pharma

FEBRUARY 22, 2018

While at home in Australia, the Medical Cannabis industry is still working hard to gather more evidence-based research to substantiate treatment assertions, relevant studies are already occurring overseas. It’s heartening to see the release of more and more evidence-based global research surrounding Medical Cannabis-based treatment.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

MMJ Recs

JUNE 9, 2024

West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. In this guide, we’ll break down everything you need to know to start accessing medical marijuana in West Virginia.

Access 52

Access Marijuana Patients Programs 52

MMJ Recs

JULY 9, 2024

Living with chronic conditions such as Multiple Sclerosis (MS) is profoundly challenging and impacts various aspects of daily life. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

AUGUST 17, 2022

Researchers wanted to evaluate the potential association between cannabis use and respiratory-related emergency room visits and hospitalizations. This study was observational in the sense that the researchers did not directly interact with participants and merely conducted reviews of health records and surveys. Focused on the Negative.

Research and Development 105

Research and Development Topical Data Cannabis 105

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Veriheal

DECEMBER 9, 2021

Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

JULY 19, 2021

Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction. We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Veriheal

JANUARY 28, 2022

The developmental condition can be difficult to manage in severe cases, putting the individual and their family members under a great deal of stress. A team of researchers at Tel Aviv University in Tel Aviv, Israel, led by Ph.D. The researchers were able to alleviate the symptoms of autism in animal models using THC-rich cannabis oil.

Oil 104

Oil THC Research and Development Treatment 104

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

JUNE 20, 2023

In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine. Meanwhile, the research team remains committed to identifying even more accurate molecules for potential therapeutic applications.

Medicine 98

Medicine Research and Development Treatment Conditions 98

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 111

Consumption Patients Research and Development Data 111

Veriheal

AUGUST 15, 2022

This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels. The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102